Completed OBSERVATIONAL NCT00772473

Correlation of Calcitonin Gene-Related Peptide (CGRP) Levels in Saliva With the Evolution of an Attack of Migraine

Sponsor: Clinvest

Updated 11 times since 2017 Last updated: May 22, 2009 Started: Feb 29, 2008 Primary completion: Jan 31, 2009 Completion: Jan 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Headache, Migraine and is currently completed. Clinvest leads this study, which shows 11 recorded versions since 2008 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jun 2022 — Jul 2024 [monthly]

Completed
Dec 2021 — Jun 2022 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed

▶ Show 6 earlier versions

Nov 2020 — Jan 2021 [monthly]

Completed
Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Clinvest
Merck Sharp & Dohme LLC

Data source: Clinvest

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Springfield, United States